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Red blood cells (RBCs) play a critical role in oxygen transport, and are the focus of important
diseases including malaria and the haemoglobinopathies. Proteins at the RBC surface can
determine susceptibility to disease, however previous studies classifying the RBC proteome
have not used specific strategies directed at enriching cell surface proteins. Furthermore,
there has been no systematic analysis of variation in abundance of RBC surface proteins
between genetically disparate human populations. These questions are important to inform
not only basic RBC biology but additionally to identify novel candidate receptors for malarial
parasites. Here, we use ‘plasma membrane profiling’ and tandem mass tag-based mass
spectrometry to enrich and quantify primary RBC cell surface proteins from two sets of nine
donors from the UK or Senegal. We define a RBC surface proteome and identify potential
Plasmodium receptors based on either diminished protein abundance, or increased variation in
RBCs from West African individuals.
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Red blood cells (RBCs) are the most abundant circulatinghuman cell type and are essential for blood gas transport.The inter-individual variation in red blood cell surface
proteins defines the range of clinically observed blood types, from
the main Rhesus grouping to more minor Landsteiner-Weiner
system1. Appreciation of the variability of RBC surface proteins is
vital to the understanding of transfusion compatibility between
donors and recipients, and conditions such as haemolytic disease
of the newborn2.
Proteins at the surface of RBC also play a critical role in sus-
ceptibility to blood borne diseases. For example, an increasing
number of proteins are recognised as receptors for Plasmodium
species, causative agents of malaria. Antigens of the Duffy blood
group system were classically described as receptors for Plasmo-
dium vivax3. More recently, additional molecules have been
identified as receptors for P. vivax or P. falciparum species. These
include basigin, complement receptor 1 (CR1/CD35), CD55
(complement decay-accelerating factor/Cromer blood group),
CD44 (Indian blood group), glycophorin molecules, the Langereis
blood group protein ABCB6 and Transferrin receptor (TFRC)4–10.
Long-standing selective pressures from pathogens such as Plas-
modium species in populations in which malaria is endemic have
led to selection against Duffy antigens11,12. For example, more
than 95% of West African populations are Duffy negative13.
Individuals who are genetically null for other receptors have also
been reported, including CD55 and ABCB614,15. Furthermore,
variable expression of CR1 is well recognised, and the level of
CR1 expression correlates with binding to the P. falciparum
ligand PfRh45. It is therefore possible that selective pressures
from Plasmodium may have driven variation in other cell surface
proteins that have as yet unknown roles in parasite invasion,
manifest either as a genetic null phenotype, or more subtly as
increased variation in the level of surface expression of the
molecule in highly exposed compared to unexposed populations.
There have been several previous studies of the red blood
proteome, although none directed specifically at proteins exposed
at the cell surface. As >98% of the protein content of RBC is
composed of haemoglobin subunits and carbonic anhydrase,
proteomic measurement of other less abundant proteins has been
more complex. Various methods have been used to selectively
enrich these proteins for proteomics, ranging from isolation of
‘white ghost’ membranes, to absorption of the highly abundant
haemoglobin prior to analysis16–25. These techniques nevertheless
still suffer from contamination by abundant intracellular proteins
and offer limited insight into which proteins have extracellular
domains.
Here we used selective oxidation and aminooxybiotinylation to
label and enrich red blood cell surface proteins, (‘Plasma Mem-
brane Profiling’, PMP)7,26. We have previously shown that this
approach has the power to quantify the majority of all cell surface
proteins, identifying for example a critical drug transporter in
cells latently infected with cytomegalovirus, in addition to a novel
malaria receptor6,27. By combining this technology with multi-
plexed tandem-mass tag (TMT)-based MS3 proteomics, we were
able to measure the variation in abundance of individual cell
surface proteins from individual to individual within nine donors
from each of two geographically and genetically distinct human
populations, one from West Africa (Senegal) and one from
the United Kingdom. We reasoned that either decreased
protein abundance or increased variation in protein expression
from Senegalese compared to UK RBC would enable identifica-
tion of putative Plasmodium receptor candidates for future
characterisation. Finally, by comparing our results to previously
published accounts of whole or membrane-enriched RBC pro-
teomes, we defined a ‘sensitive’ and ‘stringent’ list of RBC surface
proteins.
Results
Optimised enrichment of RBC for proteomic analysis. Previous
analyses of the RBC proteome have been complicated by the
presence of contaminants in the RBC sample, including white
blood cells, platelets and serum proteins. A simple method was
therefore developed to isolate fresh RBC for proteomic analysis at
maximum purity and yield, with minimum ex vivo manipulation.
Methods for enrichment have previously included combina-
tions of strategies to: deplete leukocytes (α-cellulose, density
gradient or simple centrifugation and negative selection using
magnetic beads), remove platelets (PBS washing, and positive
erythrocyte selection using magnetic beads) and remove plasma
constituents (simple centrifugation and PBS washing)16,17,19–23.
A selection of these methods was compared, initially using flow
cytometry as a readout to measure residual contamination with
platelets and leukocytes (Supplementary Fig. 1a–c). A sensitive
proteomic approach then measured contamination by serum
components (Supplementary Fig. 1d–g, Supplementary Data 1).
An optimised method involved centrifugation of 2 × 1 ml antic-
oagulated blood at 1000 g for 5 min followed by isolation of 150 μl
of packed RBC from the very bottom of each Eppendorf tube.
Cells were resuspended in PBS, passed through a Plasmodipur
filter then washed two further times.
Proteomic analysis of RBC PM proteins. Previous studies have
attempted to analyse the RBC membrane proteome by cellular
lysis followed by isolation of the membrane fraction (‘white
ghosts’)25,28, or by metal ion chromoaffinity to deplete hae-
moglobin16. However, both are still subject to substantial con-
tamination by abundant soluble intracellular proteins including
haemoglobin, and lack specificity for surface proteins with
extracellular domains. The use of ‘Plasma Membrane Profiling’
(PMP) specifically enriches cell surface glycoproteins via selective
oxidation then aminooxy-biotinylation with reagents that are
membrane impermeable at 4 °C. Isolation of biotinylated proteins
using streptavidin beads facilitates removal of major cytosolic
contaminants including haemoglobin by extensive washing of
beads using stringent conditions. Relative quantitation of each
protein across all donors could be achieved after protein digestion
with trypsin by labelling peptides with TMT tags followed by MS3
mass spectrometry10,26 (Fig. 1a).
We applied these techniques to two sets of fresh RBC samples
from nine donors with Caucasian UK heritage and nine donors
with Senegalese heritage, identifying 1260 proteins with 1041 at
the level of two or more peptides. To identify high confidence PM
proteins, a stringent approach required ≥2 peptides for each
identified protein and at least one of the following annotations
derived from the Uniprot subcellular localisation database:
‘Multipass’, ‘GPI anchored’, ‘Lipid Anchored’, ‘Type I transmem-
brane’, ‘Type II transmembrane’, ‘Type III transmembrane’, ‘Type
IV transmembrane’, or ≥1 predicted transmembrane regions
based on TMHMM version 2.029 (Fig. 1b, Methods). Six proteins
likely to be abundant serum contaminants were excluded
(Clusters C1–C2, Supplementary Fig. 1d, Supplementary Data 1).
This yielded a list of 241 and 256 cell surface proteins from UK
and Senegalese populations respectively, with 267 proteins
quantified in either population and 230 proteins quantified in
both (Supplementary Data 2a–b).
A consensus RBC surface proteome. Previous applications of
proteomics to characterise RBC proteins have classified sub-
stantially different numbers of proteins at the cell surface. To
develop a consensus RBC cell surface proteome, our data was
initially compared to 10 previous publications that used high-
throughput proteomics to measure the total RBC, or RBC
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membrane proteome, and applied the same subcellular location/
TMHMM filters described above (Fig. 1a–c)16,17,19–25. A total of
1563 proteins were identified in one or more studies (Fig. 1c,
Supplementary Data 3a–b). Hierarchical cluster analysis revealed
a central ‘core’ of high confidence RBC surface proteins, with 160
proteins found in our experiments and at least three previously
published studies (‘stringent criteria’, Supplementary Data 3c),
and 240 proteins identified by a minimum of our experiments
and at least one previous study (‘sensitive criteria’, Supplementary
Data 3d). These included key blood group proteins GYPA, GYPC,
BCAM, SLC4A1, KEL, AQP1, CD55, SLC14A1, XK and RHCE.
The utility of these criteria to characterise genuine RBC PM
proteins was illustrated by identifications of contaminating pla-
telet markers ITGB3 and ITGA2B, which are not expressed by
mature erythrocytes. Both entries were present in the ‘sensitive’
list, but neither on the ‘stringent’ list, and were likely to be
detected due to the presence of a very low percentage of residual
platelets (<0.01%, Supplementary Fig. 1b).
Figure 1b also highlights that a substantial number of proteins
were only identified in one or two of the ten previous studies.
These include a number of proteins found at high abundance in
human serum that are likely to be contaminants, for example
complement component C1Q and apolipoproteins L1 and L2
(Supplementary Data 3b). 27 proteins were only identified in the
present study (Supplementary Data 3e). Some of these are likely to
represent previously undetected low-abundant RBC PM proteins,
enriched by our plasma membrane-specific technique, including
four multi-pass transmembrane solute carrier (SLC) transporters.
At least eight are likely to be contaminants from serum or other
low-abundant contaminating cells (Supplementary Data 3e).
Despite using a stringent RBC isolation protocol, the presence of
remaining low abundance serum contaminants in our study
highlight the high sensitivity of the mass spectrometers used.
Combining and comparing multiple RBC proteomic datasets from
the literature and acquired in orthogonal manners is therefore an
important step to define a true RBC surface proteome.
Composition of the surface proteome. Intensity based absolute
quantitation (iBAQ) was employed to compare the copy number
of each protein in the ‘sensitive’ list, and thus the contribution of
each protein to the RBC cell surface proteome30. Since iBAQ is
based on the summed intensity for each protein (divided by the
number of observed peptides), values effectively represent an
average across nine donors for each population. This offers the
opportunity to provide precise information on the overall
population abundance of each PM protein, independent of
individual genetic variation. iBAQ values from both populations
correlated well (r2= 0.81), with the best quantified (most abun-
dant) proteins most similarly expressed. The most highly
expressed proteins were present at ~105 greater abundance than
the least expressed proteins (Fig. 2a). This dynamic range cor-
responds well to previous data; for example, in the original
description of the iBAQ algorithm, Schwanhaüsser et al. found
that iBAQ abundances of proteins in NIH3T3 fibroblasts also
spanned more than five orders of magnitude30.
The four most abundant surface proteins, GYPC, GYPA,
SLC2A1 and SLC4A1 accounted for ~62–75% of the surface
proteome, with GYPC alone representing ~25% (Fig. 2b).
Quantified cell surface blood group antigens (which do not
include SLC2A1) accounted for ~72–75% of the surface proteome
(Supplementary Fig. 2, Supplementary Data 2a, 4). Despite
multiple independent analyses by mass spectrometry, no unique
peptides corresponding to GYPB were identified. GYPD is an
abridged form of GYPC with an alternative start site, and no
unique N-terminal GYPD peptide was identified.
A subset of candidate receptors for Plasmodium species include
proteins whose abundance is lower in Senegalese compared to UK
populations. As expected, Duffy antigen was only detected in UK
but not Senegalese populations (Supplementary Data 2c). Several
proteins also exhibited overall statistically lower abundance in
RBC samples from Senegal, for example known Plasmodium
receptors CD55 (15.5-fold lower) and CD44 (3.1 fold lower)
(Fig. 2a, Supplementary Fig. 3, Supplementary Data 2a)6,7. Other
proteins exhibiting either of these patterns include the solute
carrier SLC44A2, the complement regulatory protein CD59 and
tetraspanin CD151 (Fig. 2a).
Variability between genetically distinct populations. Certain
cell surface proteins exhibit a genetically determined high degree
of inter-donor variability in expression, including CR1 and
complement molecules C4A and C4B31,32. By using highly mul-
tiplexed TMT-based proteomics, the present study offered the
opportunity to directly measure the variability in expression of
whole RBC surface proteomes across multiple donors. Despite
extensive washing of biotinylated proteins when bound to
streptavidin beads, variable levels of contamination with hae-
moglobin were nevertheless detectable. As opposed to normal-
isation of data assuming equal protein loading across all channels,
normalisation was instead performed from the summed signal:
noise values of the three most abundant RBC surface blood group
proteins, Glycophorin A (GYPA), Glycophorin C (GYPC) and
SLC4A1. All three exhibited low variability across all donors
studied from both populations, independent of the method of
normalisation used, validating their usefulness for this purpose
(Supplementary Fig. 4).
The majority of proteins identified in both populations
exhibited relatively little variability (61.8 % of proteins <25%
variability in both proteins, Fig. 3a, Supplementary Data 2a, e;
Data 2e is an interactive spreadsheet that can be used to visualise
any of the data in this manuscript). Using a Mann–Whitney U
test we determined that the distribution of %CV values between
both populations were similar (p-value for alternative hypothesis
of different distributions= 0.103, thus supporting the null
hypothesis, established via Monte Carlo method with 100,000
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Fig. 1 Experimental details. a Schematic of the experimental workflow.
b Schematic of workflow for filtering identified proteins. c Comparison of
this study to ten previous proteomic studies that examined either whole
RBC or enriched RBC membranes. Proteins without transmembrane regions
or membrane anchors were excluded as described in the text. A binary
outcome is shown for 1563 proteins, representing presence (red) or
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iterations). A small number of proteins were significantly more
variable in the Senegalese compared to the UK population,
including Sphingomyelin Phosphodiesterase Acid Like 3b
(SMPDL3B) and Solute Carrier 43 Member 1 (SLC43A1). Other
candidate molecules with high variability in the Senegalese
population included the SLC transporter SLC40A1 (Ferroportin),
in which the Q248H mutation has recently been reported to be
positively selected to protect against severe malaria33, and amino
acid or nucleobase transporter SCL43A334,35. The poorly
characterised protein Family With Sequence Similarity 234
Member A (FAM234A; also known as Integrin Alpha FG-GAP
Repeat Containing 3, ITFG3), which is partially deleted in a novel
α-thalassemia trait36 additionally exhibited much higher varia-
bility in Senegalese samples.
To determine if measured protein variability was a product of
decreased cell surface abundance, the correlation between the
percentage coefficient of variance (%CV; standard deviation
divided by the mean) and iBAQ values in both populations was
examined. Data were poorly correlated, as would be expected
from an unbiased assessment of variability. As expected, the
highly abundant proteins used for data normalisation including
GYPA exhibited some of the lowest variability (Supplementary
Fig. 5).
Flow cytometry was used to validate proteomic data. As only
UK RBC donors were readily available for confirmatory
experiments, a fresh set of UK donor samples was used to
examine the variability in two relatively invariant, and two
relatively more variable cell surface proteins. The proteins GYPA
and SLC4A1 were amongst the least variable proteins in the UK
donor RBC samples (Supplementary Fig. 5), which was confirmed
by flow cytometry (Fig. 4a, b).
The blood group antigens ICAM4 (Landsteiner-Weiner) and
CD35/CR1 (Knops) were variably expressed between donors and
of intermediate abundance (Supplementary Fig. 5) suggesting
flow cytometry-based assessment would be likely to yield a
precise result. The %CV in median fluorescence intensity for both
proteins corresponded very well to proteomic data, even though
measurements were made on samples from different
donors, validating this approach (Fig. 4a, b, Supplementary
Data 5). Furthermore, studies of RBC from two donors over
four weeks suggested that the cell surface proteins studied are
stably expressed over time within an individual (Supplementary
Fig. 6).
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Discussion
RBC have vital roles in vertebrate physiology. Although a number
of studies have examined the composition of the whole, or
membrane RBC proteome, none have used an approach specifi-
cally directed at the cell surface. An appreciation of which pro-
teins are expressed at the RBC surface, their relative abundance
and variation in expression between different populations is vital
to understanding diseases caused by pathogens including Plas-
modium and Babesia.
In this study we used a plasma membrane-targeted proteomic
approach to compare the composition and variability of the RBC
surface proteome between UK and Senegalese populations. Our
selective enrichment of cell surface glycoproteins via specific
amino-oxybiotinylation prior to RBC lysis offers inherent
advantages over previous strategies. In particular, this enables
extensive on-bead washing to limit sample contamination with
highly abundant intracellular proteins, and selective targeting of
molecules with extracellular domains to distinguish surface-
expressed proteins from those residing exclusively in intracellular
membrane pools. In combination with stringent RBC isolation
procedures and bioinformatic analysis, this enabled identification
of 240 high confidence RBC cell surface proteins, and assessment
of the relative contribution of each to the RBC surface proteome.
Our data will thus form an important resource for future inves-
tigations of the red blood cell surface in health and disease.
Phenotypic variation between RBCs from different donors is a
critical driver of transfusion reactions, and plays important roles
in determining susceptibility to specific pathogens or stresses.
Our application of highly multiplexed TMT-based MS3 mass
spectrometry enabled an unprecedented comparison of protein
expression both between multiple individuals from a given
population, and between RBC from distinct populations. Never-
theless, as our studies were necessarily limited to examining nine
individuals from each population due to the multiplexing limits
of TMT, data may not fully represent variation at a whole
population level, and the statistical relevance of these data may
similarly be limited. In addition to recapitulating known positive
controls (such as detection of Duffy antigen only in UK but not
Senegalese samples), a number of proteins exhibited significantly
decreased abundance on Senegalese RBCs. These included com-
plement regulatory proteins CD55 (Decay Accelerating Factor)
and CD59 (Membrane Attack Complex Inhibition Factor) in
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addition to the presumptive choline transporter and thrombosis
susceptibility protein SLC44A237. Other amino acid transporters
exhibited greater variability in Senegalese compared to UK RBCs,
including SLC43A1 and SLC43A3. Although mature red blood
cells are not transcriptionally or translationally active, amino acid
metabolites are nevertheless used as substrates to synthesise
glutathione, which is critical for maintaining the redox state of the
red blood cell38. Other red blood cell polymorphisms that
maintain redox state, for example Glucose-6-Phosphate Dehy-
drogenase deficiency, have been established to play a protective
role against malaria39. FAM234A protein was also significantly
more variably expressed in Senegalese donors. The function of
FAM234A is poorly characterised, although single nucleotide
polymorphisms within this gene have been associated with var-
iation in RBC mean corpuscular volume and haemoglobin con-
centration in African-American populations40. Whether this
reflects a direct influence of FAM234A on red blood cell char-
acteristics or alternatively effects of a closely linked gene remains
unclear.
In addition to evolutionary history and founder effects, the
origin of increased variability in expression of FAM234A,
SLC43A1 and SLC43A3 and other proteins in the Senegalese
population may be explained by selective pressures from a variety
of pathogens. These include (1) negative selective pressure against
certain RBC surface receptors for P. falciparum, an endemic
pathogen in sub-Saharan Africa; (2) previous negative selective
pressure from P. vivax, which was but is no longer an endemic
pathogen41; (3) current selective pressure by another pathogen
(for example, arenaviruses such as Machupo virus). Nutritional
differences between and within the studied populations may also
modulate surface protein expression42. Future work will be
required to address these questions in regards to data from the
present study.
Overall, our data provides both a shortlist of potential novel
receptors for Plasmodium for further study, in addition to com-
prehensive definition of the RBC surface proteome, which will
facilitate diverse future studies of RBC biology.
Methods
RBC isolation. Collection of clinical samples from healthy donors from the
Senegalese National Blood Transfusion Center in Dakar, Senegal, and their
experimental use were approved by the Ethics Committee of the Ministry of Health
in Senegal and by the Institutional Review Board of the Harvard T.H. Chan School
of Public Health. For samples derived from donors local to Cambridge, UK, ethical
approval was obtained from University of Cambridge Human Biology Research
Ethics Committee (HBREC.2016.011). In all, 2–3 ml of whole anticoagulated blood
was collected from each donor with informed consent in accordance with the
Declaration of Helsinki.
Methods for RBC enrichment. The following techniques were used alone or in
combination to optimise enrichment of erythrocytes for plasma membrane (PM)
proteomic analysis, as detailed in the Results section:
Microcentrifugation: 1 ml of whole blood was centrifuged at 1000 g for 5 min in
a 1.5 ml Eppendorf tube. A 200 μl pipette tip was used to withdraw packed
erythrocytes from the very bottom of the tube.
Plasmodipur filtration to remove leukocytes: Erythrocytes were resuspended in
50 ml room temperature PBS (Sigma). A Plasmodipur filter (EuroProxima) was
mounted on a 50 ml syringe and gentle pressure was applied to filter cells.
PBS washes to remove platelets and serum contaminants: Erythrocytes were
resuspended in 50 ml room temperature PBS (Sigma) and centrifuged at 400 g for
5 min. Residual PBS was aspirated.
MACS microbead kits: A CD45 microbead kit (Miltenyi Biotech, 135-045-801)
was used with 250 μl whole blood to negatively select leukocytes. A CD235
microbead kit (Miltenyi Biotech, 130-050-501) was used with 100 μl whole blood to
positively select erythrocytes. Both kits were used according to the manufacturer’s
instructions.
Final optimised protocol (see also Results section): For each sample, 2x aliquots
of 1 ml anticoagulated whole blood were centrifuged for 5 min at 1000 g in a 1.5 ml
eppendorf. 150 μl was removed from the very bottom of each tube, and combined
into 50 ml PBS, followed by Plasmodipur filtration. After centrifugation for 5 min
at 400 g, two further 50 ml PBS washes were performed. The resulting enriched
RBC were directly subjected to PMP.
RBC storage. To facilitate simultaneous immunostaining for temporal flow cyto-
metry analysis in supplementary fig. 6, RBC were stored in a high glycerol solution
using a method adapted from a previously published protocol43. Briefly, RBC were
isolated from packed spun whole blood as described above. Cells were then dis-
persed in a 40% glycerol solution and slowly cooled to −80 °C for storage. Glycerol
was removed on the day of immunostaining and osmolality slowly reduced before
returning to isotonic conditions. RBC were then immunostained as
described below.
Plasma membrane profiling. We have described plasma membrane profiling
previously10,26, and details of the method used is recapitulated here with mod-
ifications for this study. For ~1.5 × 109 of each enriched erythrocyte sample, surface
sialic acid residues were oxidized with sodium meta-periodate (Thermo) then
biotinylated with aminooxy-biotin (Biotium). After quenching, cells were incu-
bated in 1% (v/v) Triton X-100 lysis buffer (10 mM Tris HCl, 1.6% Triton, 150 mM
NaCl). Biotinylated glycoproteins were enriched with high affinity streptavidin
agarose beads (Pierce) and washed extensively. Captured protein was denatured
with dithiothreitol (DTT), alkylated with iodoacetamide (Sigma) and digested on-
bead with trypsin (Promega) in 200 mM HEPES pH 8.5 for 3 h. Tryptic peptides
were collected and labelled using TMT reagents. The reaction was quenched with
hydroxylamine, and TMT-labelled samples combined in a 1:1:1:1:1:1:1:1:1:1 ratio.
Labelled peptides were subjected to C18 solid-phase extraction (Sep-Pak, Waters)
and vacuum-centrifuged to near-dryness.
Offline fractionation and mass spectrometry. The mass spectrometry protocols
employed were similar to previous studies44, and are recapitulated here with
modifications for the present study. Mass spectrometry data was acquired using an
Orbitrap Lumos for samples from UK donors, and an Orbitrap Fusion for samples
from Senegal donors. In both cases, an Ultimate 3000 RSLC nano UHPLC
equipped with a 300 µm ID × 5 mm Acclaim PepMap µ-Precolumn (Thermo
Fisher Scientific) and a 75 µm ID × 50 cm 2.1 µm particle Acclaim PepMap RSLC
analytical column was used.
For Orbitrap Lumos experiments: An unfractionated singleshot of 25% of the
whole sample was analysed. Subsequently, the remaining 75% of the sample was
separated into six fractions using tip-based strong cation exchange26. Loading
solvent was 0.1% Formic Acid (FA) analytical solvent A: 0.1% FA and B: 80%
acetonitrile+ 0.1% FA. All separations were carried out at 55 °C. Samples were
loaded at 5 µL/min for 5 min in loading solvent before beginning the analytical
gradient. The singleshot sample was analysed on the following gradient: 3–7% B
over 3 min, 7–37% B over 173 min, followed by a 4 min wash at 95% B and
equilibration at 3% B for 15 min. Each of six fractions were analysed on the
following gradient: 3–8% B over 3 min, 8–37% B over 88 min, followed by a 2 min
wash at 95% B and equilibration at 3% B for 15 min. Each analysis used a
MultiNotch MS3-based TMT method45,46. The following settings were used: MS1:
380–1500 Th, 120,000 Resolution, 2 × 105 automatic gain control (AGC) target, 50
ms maximum injection time. MS2: Quadrupole isolation at an isolation width of
m/z 0.7, CID fragmentation (normalised collision energy (NCE) 35) with ion trap
scanning in turbo mode from m/z 120, 1.5 × 104 AGC target, 120 ms maximum
injection time. MS3: In Synchronous Precursor Selection mode the top three MS2
ions were selected for HCD fragmentation (NCE 65) and scanned in the Orbitrap
at 60,000 resolution with an AGC target of 1 × 105 and a maximum accumulation
time of 150 ms. Ions were not accumulated for all parallelisable time. The entire
MS/MS/MS cycle had a target time of 3 s. Dynamic exclusion was set to ±10 ppm
for 70 s. MS2 fragmentation was trigged on precursors 5 × 103 counts and above.
For Orbitrap Fusion experiments: As the samples analysed on the Orbitrap
Lumos contained substantial peaks likely to relate to abundant contaminants such
as trypsin, TMT-labelled tryptic peptides were instead separated by high pH
reversed-phase (HpRP) fractionation44. Peptide containing fractions were then
orthogonally recombined into six fractions. Fractions identified by UV absorbance
as containing very abundant peptide were omitted from this recombination
procedure and instead combined into a separate, seventh fraction. For LC/MS3,
loading solvent was 0.1% trifluoroacetic acid (TFA), analytical solvent A: 0.1% FA
and B: acetonitrile+ 0.1% FA. All separations were carried out at 55 °C. Samples
were loaded at 10 µl/min for 5 min in loading solvent before beginning the
analytical gradient. The following gradient was used: 3–8% B over 3 min, 8–37% B
over 85 min, 37–95% B over 4 min followed by a 3 min wash at 95% B and
equilibration at 3% B for 15 min. Each analysis used a MultiNotch MS3-based
TMT method45,46. The following settings were used: MS1: 400–1400 Th,
Quadrupole isolation, 120,000 Resolution, 2 × 105 AGC target, 50 ms maximum
injection time, ions injected for all parallisable time. MS2: Quadrupole isolation at
an isolation width of m/z 0.7, CID fragmentation (NCE 30) with ion trap scanning
out in rapid mode from m/z 120, 1 × 104 AGC target, 70 ms maximum injection
time, ions accumulated for all parallisable time in centroid mode. MS3: in
Synchronous Precursor Selection mode the top 10 MS2 ions were selected for HCD
fragmentation (NCE 65) and scanned in the Orbitrap at 50,000 resolution with an
AGC target of 5 × 104 and a maximum accumulation time of 150 ms, ions were not
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accumulated for all parallelisable time. The entire MS/MS/MS cycle had a target
time of 3 s. Dynamic exclusion was set to ±10 ppm for 90 s. MS2 fragmentation was
trigged on precursors 5 × 103 counts and above.
Quantification and statistical analysis. Data analysis: the data analysis protocols
employed were similar to previous studies44, and are recapitulated here with
modifications for the present study. In the following description, we list the first
report in the literature for each relevant algorithm. Mass spectra were processed
using a Sequest-based software pipeline for quantitative proteomics, ‘MassPike’,
through a collaborative arrangement with Professor Steve Gygi’s laboratory at
Harvard Medical School. MS spectra were converted to mzXML using an extractor
built upon Thermo Fisher’s RAW File Reader library (version 4.0.26). In this
extractor, the standard mzXML format has been augmented with additional cus-
tom fields that are specific to ion trap and Orbitrap mass spectrometry and
essential for TMT quantitation. These additional fields include ion injection times
for each scan, Fourier Transform-derived baseline and noise values calculated for
every Orbitrap scan, isolation widths for each scan type, scan event numbers, and
elapsed scan times. This software is a component of the MassPike software plat-
form and is licensed by Harvard Medical School.
A combined database was constructed from the human Uniprot database (26
January 2017), and common contaminants such as porcine trypsin. The
combined database was concatenated with a reverse database composed of all
protein sequences in reversed order. Searches were performed using a 20 ppm
precursor ion tolerance47. Product ion tolerance was set to 0.03 Th. TMT tags
on lysine residues and peptide N termini (229.162932 Da) and
carbamidomethylation of cysteine residues (57.02146 Da) were set as static
modifications, while oxidation of methionine residues (15.99492 Da) was set as
a variable modification.
To control the fraction of erroneous protein identifications, a target-decoy
strategy was employed48,49. Peptide spectral matches (PSMs) were filtered to an
initial peptide-level false discovery rate (FDR) of 1% with subsequent filtering to
attain a final protein-level FDR of 1%50,51. PSM filtering was performed using a
linear discriminant analysis52. This distinguishes correct from incorrect peptide
IDs in a manner analogous to the widely used Percolator algorithm53, though
employing a distinct machine learning algorithm. The following parameters were
considered: XCorr, ΔCn, missed cleavages, peptide length, charge state, and
precursor mass accuracy. Protein assembly was guided by principles of parsimony
to produce the smallest set of proteins necessary to account for all observed
peptides52.
Proteins were quantified by summing TMT reporter ion counts across all
matching peptide-spectral matches using ‘MassPike’45,46. Briefly, a 0.003 Th
window around the theoretical m/z of each reporter ion (126, 127n, 127c, 128n,
128c, 129n, 129c, 130n, 130c, 131n) was scanned for ions, and the maximum
intensity nearest to the theoretical m/z was used. The primary determinant of
quantitation quality is the number of TMT reporter ions detected in each
MS3 spectrum, which is directly proportional to the signal-to-noise (S:N) ratio
observed for each ion54. Conservatively, every individual peptide used for
quantitation was required to contribute sufficient TMT reporter ions (minimum of
~1250 per spectrum) so that each on its own could be expected to provide a
representative picture of relative protein abundance45. An isolation specificity filter
was additionally employed to minimise peptide co-isolation55. Peptide-spectral
matches with poor quality MS3 spectra (more than 9 TMT channels missing and/
or a combined S:N ratio of <250 across all TMT reporter ions) or no MS3 spectra at
all were excluded from quantitation. Peptides meeting the stated criteria for reliable
quantitation were then summed by parent protein, in effect weighting the
contributions of individual peptides to the total protein signal based on their
individual TMT reporter ion yields. Protein quantitation values were exported for
further analysis in Microsoft Excel.
For protein quantitation, reverse and contaminant proteins were removed.
Despite extensive washing of biotinylated proteins when bound to Streptavidin
beads, variable levels of contamination with abundant haemoglobin
components were nevertheless detectable. As opposed to normalisation
assuming equal protein loading across all channels, normalisation was instead
performed from the summed signal:noise values of the three most abundant
RBC surface proteins (which are also all recognised cell surface blood group
proteins), GlycophorinA (GYPA), Glycophorin C (GYPC) and SLC4A1 (see
Results). For further analysis and display in figures, fractional TMT signals were
used (i.e. reporting the fraction of maximal signal observed for each protein in
each TMT channel, rather than the absolute normalized signal intensity). This
effectively corrected for differences in the numbers of peptides observed per
protein.
Proteins were filtered to include those most likely to be present at the cell
surface with high confidence. These comprised proteins with Uniprot Subcellular
Location terms matching ‘Multipass’, ‘GPI anchored’, ‘Lipid Anchored’, ‘Type I
transmembrane’, ‘Type II transmembrane’, ‘Type III transmembrane’, ‘Type IV
transmembrane’, and those predicted to have transmembrane regions based on
TMHMM version 2.029. To be included in the analysis, a minimum of two peptide
quantifications were required per protein (which could be derived exclusively from
either of the UK or Senegal samples, or one peptide from both samples). Clusters
C1 and C2 (Supplementary Fig. 1D) identified a list of proteins likely to reflect
abundant serum contaminants. Data were filtered to exclude these contaminants,
in total removing six proteins (IGHM, FGG, C9, C8B, CD14 and ITIH1). Three
HLA-A species were identified in our data, likely derived from low-level
contamination with leukocytes (<0.05%, Supplementary Fig. 1B). To enable
comparison with previous literature, signal:noise values for all three alleles were
summed to give a single combined result for HLA-A.
For Supplementary Fig. 1D, the Database for Annotation, Visualisation and
Integrated Discovery (DAVID) was used to determine pathway enrichment56.
Clusters C1 and C2 were searched against a background of all proteins quantified.
Hierarchical centroid clustering based on Euclidian distance or uncentered
correlation was performed using Cluster 3.0 (Stanford University) and visualised
using Java Treeview (http://jtreeview.sourceforge.net). Subcellular Location terms
were added from www.uniprot.org.
iBAQ: To determine protein abundance, RAW files for a given donor set (UK or
Senegal) were re-analysed using MaxQuant 1.6.0.13 using the same human Uniprot
database as described above. iBAQ values were calculated and exported to
Microsoft Excel for further analysis. In the UK experiment, a single donation was
included that failed for technical reasons. For each protein, the iBAQ values were
adjusted in proportion to the total contribution derived from that donor, calculated
from the relative TMT abundance determined in MaxQuant.
iBAQ is based on the summed intensity of all peptides from each protein
divided by the number of observable peptides. Therefore the iBAQ abundance is
composed of three parts, which contribute to the overall dynamic range of
measurement. These are (a) MS1 precursor intensity for each peptide; (b) number
of peptides observed for each protein and (c) number of observable peptides from
each protein. For example, amongst proteins quantified from Senegalese donors,
ADAM9 had one of the lowest iBAQ abundances, of 3.8 × 105, and was quantified
by three peptides. By comparison, GYPC (Glycophorin C) had the highest
abundance (9.1 × 1010), and was quantified by 154 peptides. ADAM9 is composed
of 819 amino acids (41 theoretically observable peptides), whereas GYPC is 128
amino acids long (two theoretically observable peptides). The iBAQ abundance of
GYPC is higher for three reasons; (a) higher summed MS1 precursor intensities;
(b) greater number of observed peptides; (c) lower number of observable peptides.
Estimates of protein copy number per red blood cell were derived from the
fraction each protein contributed to the total iBAQ signal multiplied by an average
estimated red blood cell surface protein copy number (1.74 × 107) derived from
previous studies18,25.
Literature comparison: the existing literature on whole red blood cell proteomes
was reviewed, and the 10 highest quality mass spectrometry analyses from 2006
onwards were included in our comparison, starting with Pasini et al.16,17,19–25.
Prior to this point, most analyses had been based on 2D gel electrophoresis,
identifying a very limited range of proteins, Proteins from each manuscript were
extracted from published data resources. For data that included protein UniProt
identifiers, no further modification was required. For other data, the following
protein identification conversion tools were used: UniProt (https://www.uniprot.
org/uniprot/), DAVID (https://david.ncifcrf.gov/) and BioDB (https://biodbnet-
abcc.ncifcrf.gov/db/db2db.php)56–59.
Flow cytometric analysis of RBC surface proteins: 2 × 107 enriched RBC were
incubated with Fc blocking reagent then specific fluorophore-conjugated antibodies
at 4 °C for 30 min with Biolegend Human Trustain FcX. Antibodies used were:
anti-CD45 (Becton-Dickinson, 555482); anti-CD61 (Becton-Dickinson, 555754),
anti-ICAM4 (R&D Biosystems, FAB8397A), anti-CD35 (Miltenyi Biotec, 130-099-
913), anti-GYPA (Miltenyi Biotec, 130-100-269), anti-SLC4A1 (Miltenyi Biotec,
130-105-728). Cells were washed in PBS/0.4% (v/v) citrate/0.5% (v/v) BSA prior to
fixation and analysis on a BD LSR Fortessa. The only major deviation from this
protocol was for staining for SLC4A1, for which the antibody recognises an
intracellular epitope. As such RBC were treated with Fc blocking reagent for 30 min
prior to being permeabilised using a Cytofix/Cytoperm kit (Becton Dickinson),
then immunostained prior to flow cytometric analysis. After gating by forward and
side-scatter, ≥20,000 events were captured. Data was analysed using FlowJo V10
(FlowJo, LLC). Data for each maker was acquired from an independently stained
sample.
Statistics and reproducibility: For Fig. 2a, the method of significance A was used
to estimate the p-value that each protein ratio (iBAQ Senegal: iBAQ UK) was
significantly different to 160. As an increase in variation in iBAQ values was seen as
expected as overall protein abundance decreased, for the purposes of significance A
calculation, ratios were split into two ‘bins’ at the mid-point of abundance in the
Senegalese samples (log10 8.5). Values were calculated and corrected for multiple
hypothesis testing using the method of Benjamini-Hochberg in Perseus version
1.5.1.660. A corrected p-value of <0.01 (two-tailed) was considered statistically
significant. Calculations were based on proteins identified with both %CV and
iBAQ values in our ‘sensitive’ protein list with contaminants and duplicates
removed (n= 165).
For comparing the distribution of %CV values between proteins identified in
UK and Senegalese donors a two-tailed Mann–Whitney U-test was performed on
proteins found in both populations using XLStat (Addinsoft). P-values were
calculated using the Monte Carlo method with 100,000 iterations.
For flow cytometry validation of proteomic data, small volumes of blood were
taken from eight donors, enriched for RBC and split into samples stained
independently for each marker. A single sample was discarded due to poor sample
quality.
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Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The mass spectrometry proteomics data has been deposited to the ProteomeXchange
Consortium (http://www.proteomexchange.org/) via the PRIDE partner repository.
Project accession number PXD013852, project name ‘Quantitative comparative analysis
of human erythrocyte surface proteins between individuals from two genetically distinct
populations’. All raw flow cytometry data will be made available upon request.
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